Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

J&J’s Invokana first SGLT2 to show kidney disease benefits

J&J’s Invokana first SGLT2 to show kidney disease benefits Meanwhile Sanofi and Lexicon's Zynquista and Eli Lilly and Boehringer Ingeheim's market leader Jardiance are also both in renal outcomes trials, with their respective results expected by 2022.

Sanofi joins Lilly in insulin price cut, but lawmakers have lost patience

Sanofi joins Lilly in insulin price cut, but lawmakers have lost patience Executives from insulin producers Eli Lilly, Novo Nordisk, Sanofi and Pharmacy Benefit Managers (PBMs) CVS, Cigna’s Express Scripts and United Healthcare’s Optum faced a near three-hour dressing down ... Lilly’s recent move to launch a cut-price

NICE says no to Novartis’ Kisqali combo in breast cancer

NICE says no to Novartis’ Kisqali combo in breast cancer Double blow after Lilly rival recommended. Novartis’ hopes of a boost for under-performing breast cancer drug Kisqali have been hit by a negative verdict from NICE. ... Early signs are that Lilly’s drug is starting to accelerate even as Kisqali slows

Novartis and Amgen come to blows over migraine partnership

Novartis and Amgen come to blows over migraine partnership It has since been followed by Teva’s Ajovy (fremanezumab) and Eli Lilly’s Emgality (galcanezumab), which have similar dosing requirements.

Teva’s migraine injection approved in Europe

Teva’s migraine injection approved in Europe for migraine prevention, gaining European approval in August last year, followed by Lilly's Emgality in November.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics